Last updated on March 2019

Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer


Brief description of study

The purpose of this study is to evaluate the safety and efficacy of the study drug abemaciclib in participants with high risk, node positive, early stage, hormone receptor positive (HR+), human epidermal receptor 2 negative (HER2-), breast cancer.

Clinical Study Identifier: NCT03155997

Contact Investigators or Research Sites near you

Start Over

Daniela Katz

Assaf Harofeh Medical Center
Zerifin, Israel

Noa Ben Baruch Efrat

Kaplan Medical Center
Rehovot, Israel
4.78miles

Einav Gal-Yam

Sheba Medical Center
Ramat Gan, Israel
7.73miles

Salomon Stemmer

Rabin Medical Center
Petach Tikva, Israel
9.17miles

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.